Clinical Trial Update: CRP, Procalcitonin and Pro-BNP as Diagnostic and Prognostic Markers in AECOPD

View source ↗

Summary

The completed trial evaluated inflammatory and cardiac biomarkers (CRP, procalcitonin, and pro-BNP) for diagnosing and prognosticating acute COPD exacerbations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Kanuni Sultan Suleyman Training and Research Hospital | Conditions: COPD Exacerbation Acute | Status: COMPLETED